|

Fludarabine + Cyclophosphamide combination Clinical Trials

2 actively recruiting trials across 1 location

No change since June 2026

Also known as: Fludara; Cytoxan

Pipeline

Phase 1: 2

Top Sponsors

  • University of Pennsylvania2

Indications

  • Cancer2
  • Cholangiocarcinoma1
  • Pancreatic Adenocarcinoma1
  • Glioblastoma1
  • Colorectal Cancer1

Philadelphia, Pennsylvania2 trials

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

University of Pennsylvania

Phase 1
TCR1188-ABC Cells in KRAS-mutated Cancers

University of Pennsylvania

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.